Eisai Expands Relationship With Johns Hopkins For Neurological Disorders, Partnering Through "Open Innovation"
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Eisai Co. Ltd. will build on its existing relationship with the Johns Hopkins Brain Science Institute, announcing a drug discovery collaboration for neurology Oct. 17
You may also be interested in...
Eisai, Astellas Launch New Initiatives For Neglected Tropical Diseases For Corporate Responsibility And To Plant Seeds For New Markets
Japanese pharmas’ interest in market expansion is leading companies to increase activity in global medicine access issues.
Eisai, Astellas Launch New Initiatives For Neglected Tropical Diseases For Corporate Responsibility And To Plant Seeds For New Markets
Japanese pharmas’ interest in market expansion is leading companies to increase activity in global medicine access issues.
Spurred By Necessity, Industry And Academia Are Learning To Share
After a prior era of failed collaborations, industry and academia are increasingly joining forces in ways that better accommodate each others’ capabilities and goals – and, they hope, will create more value and ultimately greater improvements to human health.